Legal Opinion
New Jersey Carpenters Pension & Annuity Funds v. Biogen Idec Inc.
Court of Appeals for the First Circuit
Decided August 7, 2008No. 07-2626PublishedCited by 65 opinions
1Opinion of the Court
LYNCH, Chief Judge.
In this securities case, a drug company, Biogen Idee Inc., conducted clinical trials and received accelerated FDA approval for TYSABRI, a promising new drug for multiple sclerosis and similar autoimmune diseases. The' price of the company stock increased as FDA approval was sought and granted. Less than three months after the approval, on February 18, 2005, continuing clinical trials of the drug revealed that two patients had contracted a type of infection perhaps associated with the drug. One of those patients had died. Within ten days, on February 28, 2005, the company,…
2Cases cited34 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
- TSC Industries, Inc. v. Northway, Inc.Supreme Court of the United States · 1976
29 more not listed; retrieve them via the Exa API.
3Cited by65 opinions
- Lormand v. US Unwired, Inc.Court of Appeals for the Fifth Circuit · 2009
- Cozzarelli v. Inspire Pharmaceuticals Inc.Court of Appeals for the Fourth Circuit · 2008
- United States Ex Rel. Ge v. Takeda Pharmaceutical Co.Court of Appeals for the First Circuit · 2013
- Fire and Police Pension Assoc v. Abiomed, Inc.Court of Appeals for the First Circuit · 2015
- In Re Boston Scientific Corp. Securities LitigationCourt of Appeals for the First Circuit · 2012
60 more not listed; retrieve them via the Exa API.